Validation of the Neuropsychological Assessment Battery Screening Module (NAB-SM) in patients with traumatic brain injury
Author
Hacker, David AnthonyJones, Christopher A
Michael, Tom
Hawkins, Andrew
Clowes, Zoe
Yasin, Eyrsa
Belli, Antonio
O'Neill, Nicci
Parnham, Jacqueline
Ustianowski, Michaela
Wardall, Hannah
Affiliation
University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Walsall Healthcare NHS Trust;Publication date
2022-09
Metadata
Show full item recordAbstract
This study cross-validates the screening module of the Neuropsychological Assessment Battery (NAB-SM) with a battery of well validated neuropsychological tests (Convergent Validity Test Battery: CVTB) in a Traumatic Brain Injury (TBI) population. Forty-four participants with "mild-complicated" to "severe" TBI were recruited from a cohort of patients attending an outpatient clinic at a UK major trauma center. The NAB-SM Total Index score and an abbreviated short-form, from which a TBI Index was derived, both showed good classification accuracy in predicting impairment as measured by the CVTB mean score. These indices also accurately identified impairment as defined by the base rate of low scores across individual CVTB indices measuring mental processing speed, working memory, memory and executive functioning. The NAB-SM and its derived TBI index therefore have significant utility as a cognitive screening tool for use in either inpatient (acute) or outpatient TBI populations.Citation
Hacker DA, Jones CA, Michael T, Hawkins A, Clowes Z, Yasin E, Belli A, O'Neill N, Parnham J, Ustianowski M, Wardall H. Validation of the Neuropsychological Assessment Battery Screening Module (NAB-SM) in patients with traumatic brain injury. Appl Neuropsychol Adult. 2022 Sep-Oct;29(5):1103-1111.Type
ArticlePMID
33284646Journal
Applied Neuropsychology: AdultPublisher
Taylor and Francis Groupae974a485f413a2113503eed53cd6c53
10.1080/23279095.2020.1852237